$8.89
+0.48 (+5.71%)
Analyst Consensus
Strong Buy
12
Analysts
Moderate
Coverage
Price Target
Analyst Price Target
+208.2% upside
Low Target
$23.46
Average Target
$27.40
High Target
$40.51
Current Price
$8.89
Current
$8.89
$8.89
Target
$27.40
$27.40
$23.46
$27.40 avg
$40.51
Scenario Analysis
Bear Case
$23.46
163.9%
Low target
Base Case
$27.40
+208.2%
Avg target
Bull Case
$40.51
+355.7%
High target
Risk/Reward
2.2x
Favorable
Price in Context
52-Week High
$38.21
-76.7% from high
52-Week Low
$20.87
+-57.4% from low
Target vs 52W High
$27.40
-28.3% vs high
Next Earnings Report
Feb 23, 2026 · Before Market Open
7d
until earnings
EPS Est: $-0.30
Earnings in 7 days. Analyst targets may shift significantly after the report.
Peer Consensus — Biotechnology
| Stock | Consensus | Analysts | Buy % | Target | Upside |
|---|---|---|---|---|---|
| ABBV | Buy | 37 | 68% | $257.58 | +15.3% |
| AMGN | Hold | 41 | 54% | $190.87 | -50.3% |
| GILD | Strong Buy | 37 | 81% | $362.68 | +137.8% |
| VRTX | Strong Buy | 39 | 77% | $438.34 | -8.3% |
| REGN | Strong Buy | 36 | 75% | $76.80 | -90.2% |
| ALNY | Strong Buy | 36 | 75% | $102.31 | -68.8% |
| INSM | Strong Buy | 27 | 93% | $143.40 | -4.3% |
| BIIB | Hold | 42 | 48% | $91.45 | -54.5% |